Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Spyre Therapeutics has granted stock options totaling 70,200 shares to five newly hired non-executive employees as inducement awards. The options have a 10-year term, an exercise price of $48.90 per share, and will vest over four years. This move aims to attract talent and support the company's ongoing clinical development of long-acting antibody t…
Arhaus, Inc., a premium home furnishings brand, announced the opening of a 19,300-square-foot showroom in Ashburn, Virginia, marking its fifth location in the state. The showroom offers customers a curated collection of artisan-crafted furniture in a design-forward setting, complemented by complimentary design services and a relaunched Trade Progra…
First Hawaiian, Inc., Hawaii's oldest and largest bank holding company, will release its first quarter 2026 financial results on April 24, 2026, before the U.S. market opens. The company will host a conference call the same day to discuss results, accessible via phone and webcast. First Hawaiian operates banking services across Hawaii, Guam, and Sa…
IN8bio, a clinical-stage biopharmaceutical company specializing in γδ T cell therapies for cancer and autoimmune diseases, announced an inducement grant of 11,800 stock options to two new employees outside its 2023 Equity Incentive Plan. The options vest over four years and were granted in accordance with Nasdaq listing requirements to incentivize …
Xilio Therapeutics announced the granting of non-qualified stock options to two new employees as inducement awards under its 2022 Inducement Stock Incentive Plan. The options are for 3,257 shares with an exercise price of $8.48 per share, matching the closing stock price on April 1, 2026. The vesting schedule spans over four years, contingent upon …
AIOS Tech Inc. announced that Nasdaq notified the company for failing to meet the minimum $1 bid price requirement over the last 30 consecutive trading days. Nasdaq granted a 180-day period for the company to regain compliance, with the possibility of an additional 180-day extension if other criteria are met. The company is evaluating options, incl…
ORIC Pharmaceuticals announced inducement grants consisting of 80,000 stock options and 15,000 restricted stock units to a new non-executive employee who joined in March 2026. The grants are subject to vesting and were approved under Nasdaq listing rules as an employment inducement. ORIC continues its clinical stage development of oncology treatmen…
Matinas BioPharma Holdings, Inc. has received a notice from NYSE American indicating non-compliance with continued listing standards due to insufficient stockholders' equity amidst ongoing losses. The company has until May 2, 2026, to submit a compliance plan and up to 18 months to regain compliance or risk delisting. Despite the notice, its shares…
Anika Therapeutics, Inc. announced granting 3,138 restricted stock units (RSUs) to a newly hired non-executive employee as an inducement for employment, under the company's 2021 Inducement Plan and Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over a three-year period contingent on continued service. The grant was approved by the compensation …
OwlTing Group (NASDAQ: OWLS) announced a $10 million initial investment via a zero-interest convertible security, with potential follow-on funding up to $50 million, aimed at supporting the global expansion of its OwlPay payment infrastructure, regulatory licensing, and strategic growth initiatives. The funding terms offer shareholder protections a…
Hooker Furnishings Corporation announced it will release its fiscal fourth quarter and full year 2026 financial results on April 16, 2026, with a webcast and teleconference for investors. The company, specializing in casegoods, upholstered furniture, and outdoor furniture for residential and hospitality markets, highlighted its diverse brand portfo…
AH Realty Trust (NYSE: AHRT), a REIT specializing in retail and office properties primarily in the Mid-Atlantic and Southeastern US, will report its Q1 2026 earnings on May 4, followed by a management conference call on May 5. The company has a long history of real estate experience and focuses on disciplined capital allocation and long-term shareh…
Village Farms International, Inc. announced a succession plan for Chief Financial Officer Stephen Ruffini, who after 17 years will transition from CFO but remain with the company to lead mergers and acquisitions initiatives. The company will conduct a formal search for a permanent CFO replacement. The move reflects Village Farms' focus on growth th…
Plug Power Inc. announced that newly appointed CEO Jose Luis Crespo will host a Reddit AMA on April 16, 2026. The session will cover the company’s strategy, operational goals, hydrogen production facilities in the U.S., expansion of electrolyzer business globally, and Plug Power’s role in advancing the hydrogen economy. The AMA aims to engage inves…
BioCryst Pharmaceuticals announced inducement grants consisting of stock options and restricted stock units to 12 newly hired employees, as permitted under Nasdaq Listing Rule 5635(c)(4). The grants aim to attract talent by providing equity incentives with a four-year vesting schedule and ten-year option term at the closing price on the grant date.
Alta Equipment Group Inc., a leading North American equipment dealership platform, announced a quarterly dividend of $625 per Series A preferred share, payable on April 30, 2026. The dividend reflects the company's commitment to returning value to preferred shareholders while maintaining its extensive branch network across multiple U.S. states and …
Figure Technology Solutions announced preliminary operating results for March and Q1 2026, showing substantial increases in consumer loan marketplace volume, $YLDS in circulation, and activity across its Democratized Prime platform. The company continues to expand its blockchain-native capital marketplace and solidify its position as a market leade…
MiNK Therapeutics, a clinical-stage biopharmaceutical company, announced the upcoming presentation of Phase II clinical trial data evaluating their allogeneic invariant natural killer T cell therapy, agenT-797, combined with botensilimab and balstilimab in PD-1 refractory gastroesophageal cancer. The study, conducted at Memorial Sloan Kettering Can…
Kura Oncology announced inducement awards consisting of nonstatutory stock options to six new employees under its 2023 Inducement Option Plan, approved by the Compensation Committee in line with Nasdaq Listing Rule 5635(c)(4). The options grant a total of 153,750 shares at an exercise price of $8.34 per share, vesting over four years.
Lotus Technology Inc. has showcased two premier Emira models, including the new Racing Line Edition, at the 2026 New York International Auto Show. The Racing Line Edition emphasizes the brand's heritage with track-inspired design and performance enhancements, reinforcing Lotus's commitment to craftsmanship and luxury driving experiences.
MBX Biosciences, a clinical-stage biopharmaceutical company focused on precision peptide therapies for endocrine and metabolic disorders, announced an inducement grant of non-qualified stock options totaling 130,000 shares to Karen Basbaum upon her appointment as Chief Business Officer. The options have an exercise price of $32.29 per share, a 10-y…
Taysha Gene Therapies announced that it granted restricted stock units and stock options totaling 392,400 shares to four new employees as inducements for their employment. These equity awards are subject to vesting schedules and comply with Nasdaq Listing Rule 5635(c)(4). The company focuses on developing AAV-based gene therapies for severe monogen…
Bicara Therapeutics, a clinical-stage biopharmaceutical company focused on bifunctional therapies for solid tumors, announced an inducement grant of stock options to a new employee. The grant, approved under Nasdaq listing rules, includes options to purchase 44,175 shares at the closing price of $20.50 per share, vesting over time with continued em…
Rhythm Pharmaceuticals announced a change to its board of directors with the addition of Kim Popovits, an experienced biotech leader, and the departure of longtime director Ed Mathers. The company highlighted Popovits' expertise to support its ongoing growth and commercialization efforts, particularly for its rare disease treatments.
HII's Newport News Shipbuilding division has successfully completed post-shakedown availability work on the USS New Jersey (SSN 796), a Virginia-class fast attack submarine, and redelivered it to the U.S. Navy. The maintenance period included combat systems and electronics upgrades, ensuring enhanced operational readiness and reinforcing the nation…
